Removal of pharmaceuticals from municipal wastewater using a powdered activated carbon‐supplemented moving bed membrane bioreactor

Abstract BACKGROUND The new European Union Wastewater Directive 2024/3019 requires upgrading sewage treatment plants to achieve 80% removal of micropollutants. This study aimed to compare different Powdered Activated Carbon dosing strategies within a hybrid Moving Bed‐Membrane Bioreactor (PAC‐MB‐MBR) system, to evaluate its performance and to study the removal of five pharmaceuticals during wastewater treatment. RESULTS Initial batch experiments in tap water demonstrated that carbamazepine (CBZ), valsartan (VAL), and diclofenac (DCF) achieved 90% removal for all tested PAC doses, while experiments with different wastewater matrices showed that adsorption efficiency decreased in the presence of dissolved organic matter. Continuous‐flow experiments in the absence of PAC (Phase A), with a single dose of PAC at 1 g L −1 (Phase B), and a daily dose of PAC at 0.03 g L −1 (Phase C) demonstrated stable COD (>93%) and NH 4 + ‐N (>98%) removal. In the absence of PAC, CBZ and DCF were removed by 16% and 35%, respectively, while after PAC addition, the average removal of all pharmaceuticals exceeded 80%. Experiments with crossflow membrane filtration units showed that combining nanofiltration with PAC‐MB‐MBR achieved total removal exceeding 98% for all target pharmaceuticals. CONCLUSION COD and NH 4 + ‐N were effectively removed at all experimental conditions. The addition of PAC reduced extracellular polymeric substances (EPS) and soluble microbial products (SMP) concentrations and enhanced the removal of CBZ and DCF, while achieving sufficient removal efficiencies for all target pharmaceuticals. The daily addition of PAC appeared superior to a single dose. Nanofiltration experiments showed significant removal of four out of five target pharmaceuticals. © 2026 The Author(s). Journal of Chemical Technology and Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry (SCI).

Authors

Institutions

Publication Details

Journal
Journal of Chemical Technology & Biotechnology
Published
2026-07-28
DOI
https://doi.org/10.1002/jctb.70249
Primary Topic
Membrane Separation Technologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Removal of pharmaceuticals from municipal wastewater using a powdered activated carbon‐supplemented moving bed membrane bioreactor

Maria Aloupi, Olga S. Arvaniti, Georgia Gatidou, Petros Mastoras et al.
Journal of Chemical Technology & Biotechnology
Membrane Separation Technologies
article

Removal of pharmaceuticals from municipal wastewater using a powdered activated carbon‐supplemented moving bed membrane bioreactor

Maria Aloupi, Olga S. Arvaniti, Georgia Gatidou, Petros Mastoras, Athanasios S. Stasinakis, Athanasia Iliopoulou, Konstantina Adamaki, Michail S Fountoulakis, Kallisti Skarveli
article en

Abstract

Abstract BACKGROUND The new European Union Wastewater Directive 2024/3019 requires upgrading sewage treatment plants to achieve 80% removal of micropollutants. This study aimed to compare different Powdered Activated Carbon dosing strategies within a hybrid Moving Bed‐Membrane Bioreactor (PAC‐MB‐MBR) system, to evaluate its performance and to study the removal of five pharmaceuticals during wastewater treatment. RESULTS Initial batch experiments in tap water demonstrated that carbamazepine (CBZ), valsartan (VAL), and diclofenac (DCF) achieved 90% removal for all tested PAC doses, while experiments with different wastewater matrices showed that adsorption efficiency decreased in the presence of dissolved organic matter. Continuous‐flow experiments in the absence of PAC (Phase A), with a single dose of PAC at 1 g L −1 (Phase B), and a daily dose of PAC at 0.03 g L −1 (Phase C) demonstrated stable COD (>93%) and NH 4 + ‐N (>98%) removal. In the absence of PAC, CBZ and DCF were removed by 16% and 35%, respectively, while after PAC addition, the average removal of all pharmaceuticals exceeded 80%. Experiments with crossflow membrane filtration units showed that combining nanofiltration with PAC‐MB‐MBR achieved total removal exceeding 98% for all target pharmaceuticals. CONCLUSION COD and NH 4 + ‐N were effectively removed at all experimental conditions. The addition of PAC reduced extracellular polymeric substances (EPS) and soluble microbial products (SMP) concentrations and enhanced the removal of CBZ and DCF, while achieving sufficient removal efficiencies for all target pharmaceuticals. The daily addition of PAC appeared superior to a single dose. Nanofiltration experiments showed significant removal of four out of five target pharmaceuticals. © 2026 The Author(s). Journal of Chemical Technology and Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry (SCI).

Journal of Chemical Technology & Biotechnology
Frontier Science Foundation-Hellas (GR), Technical University of Crete (GR), University of the Aegean (GR)
Clean water and sanitation
Openalex Percentile: Top 17%
Membrane Separation Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.